Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 476-890-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2 June 2005 to 12 September 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 865812-80-2
- Cas Number:
- 865812-80-2
- IUPAC Name:
- 865812-80-2
Constituent 1
Method
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/beta-Naphthoflavone induced rat liver S9
- Test concentrations with justification for top dose:
- Pre-Experiment/Experiment I: 3; 10; 33; 100; 333; 1000; 2500; and 5000 µg/plate
Experiment II: 33; 100; 333; 1000; 2500; and 5000 µg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: ethanol
- Justification for choice of solvent/vehicle: the solvent was chosen because of its solubility properties and its relative non-toxicity to the bacteria.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: Without S9-mix: 4-nitro-o-phenylene-diamine (10-50 µg/plate, TA1537, TA98) // With S9-mix: 2-aminoanthracene (2.5-10 µg/plate, all strains)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation) for experiment I, preincubation method for experiment II
DURATION
- Preincubation period: 60 minutes
- Exposure duration: at least 48 hours
NUMBER OF REPLICATIONS: three plates/dose-level - Evaluation criteria:
- A test item is considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice (strains TA 98, TA 100, and WP2 uvrA) or thrice (strains TA 1535 and TA 1537) the colony count of the corresponding solvent control is observed.
A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration.
An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.
A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant. - Statistics:
- According to the OECD guideline 471, a statistical analysis of the data is not mandatory.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- On the day of the experiment, the test item ISOSTEARATE D’OXYDE DE FER was suspended in ethanol. Precipitation in the overlay agar was observed from 33 µg/plate up to 5000 µg/plate with and without metabolic activation.
The plates incubated with the test item showed normal background growth up to 5000 µg/plate with and without metabolic activation in both independent experiments.
No toxic effects, evident as a reduction in the number of revertants, occurred in the test groups with and without metabolic activation. A reduction in the number of revertants was observed in experiment I without metabolic activation in strain TA 1537 at 3 µg/plate and 333 µg/plate. Since there is no dose dependent reduction and the values are still in the range of the historical control data, this effect is not judged as a real toxic effect.
No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with iron oxide isostearate at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance.
Appropriate reference mutagens were used as positive controls. They showed a distinct increase of induced revertant colonies.
COMPARISON WITH HISTORICAL CONTROL DATA:
The data in the negative (exp. I, with S9 mix) and solvent control (exp. II, with S9 mix) of strain WP2 uvrA were slightly above our historical control range. Since this deviation is rather small, this effect is considered to be based upon biologically irrelevant fluctuations in the number of colonies.
Any other information on results incl. tables
Table 1 : Pre-Experiment/Experiment I
Test group |
Dose level (µg/plate) |
Revertant colony counts (Mean±SD) |
||||
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
WP2 uvrA |
||
Without metabolic activation |
||||||
Ethanol |
|
14±4 |
15±1 |
44±8 |
136±21 |
58±1 |
Untreated |
|
13±6 |
12±6 |
31±4 |
164±14 |
48±7 |
Iron oxide isostearate |
3 10 33 100 333 1000 2500 5000 |
12±4 14±5 16±3 p 15±1 p 13±0 p 12±2 p 12±3 p 12±4 p |
6±3 9±1 12±5 p 11±3 p 6±1 p 9±1 p 7±1 p 10±5 p |
48±27 36±6 24±3 p 25±9 p 28±5 p 39±9 p 28±6 p 31±9 p |
138±9 191±69 142±9 p 232±168 p 109±10 p 133±8 p 111±12 p 130±15 p |
55±3 59±11 71±11 p 66±1 p 84±59 p 69±2 p 59±2 p 66±8 p |
NaN3 |
10 |
1305±67 |
|
|
1919±24 |
|
4-NOPD |
10 |
|
|
356±8 |
|
|
4-NOPD |
50 |
|
92±12 |
|
|
1551±34 |
MMS |
4 |
|
|
|
|
|
With metabolic activation |
||||||
Ethanol |
|
21±7 |
18±7 |
44±8 |
157±9 |
63±5 |
Untreated |
|
21±3 |
12±6 |
39±5 |
171±7 |
61±5 |
Iron oxide isostearate |
3 10 33 100 333 1000 2500 5000 |
19±5 18±6 22±4 p 18±5 p 20±2 p 14±5 p 25±8 p 19±6 p |
15±3 11±3 13±3 p 17±5 p 10±4 p 13±4 p 11±2 p 16±4 p |
40±4 47±8 34±4 p 49±12 p 38±11 p 38±4 p 39±3 p 31±7 p |
170±12 164±12 161±3 p 147±11 p 176±11 p 167±9 p 156±8 p 133±14 p |
63±5 60±5 71±15 p 75±10 p 64±12 p 69±10 p 64±15 p 70±13 p |
2-AA |
2.5 |
409±7 |
434±23 |
2371±173 |
2724±154 |
|
2-AA |
10 |
|
|
|
|
433±30 |
Table 2 : Experiment II
Test group |
Dose level (µg/plate) |
Revertant colony counts (Mean±SD) |
||||
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
WP2 uvrA |
||
Without metabolic activation |
||||||
Ethanol |
|
19±3 |
14±6 |
38±2 |
143±14 |
55±12 |
Untreated |
|
17±4 |
17±2 |
30±3 |
157±12 |
57±3 |
Iron oxide isostearate |
33 100 333 1000 2500 5000 |
15±2 p 18±5 p 21±5 p 14±2 p 17±2 p 19±7 p |
12±7 p 10±3 p 12±3 p 10±5 p 8±2 p 11±2 p |
34±5 p 32±4 p 39±1 p 36±7 p 35±8 p 34±4 p |
148±6 p 128±11 p 124±27 p 102±7 p 99±3 p 94±11 p |
63±15 p 64±3 p 62±2 p 54±9 p 60±15 p 69±6 p |
NaN3 |
10 |
1138±84 |
|
|
1855±61 |
|
4-NOPD |
10 |
|
|
336±28 |
|
|
4-NOPD |
50 |
|
103±9 |
|
|
|
MMS |
4 |
|
|
|
|
274±152 |
With metabolic activation |
||||||
Ethanol |
|
20±4 |
14±4 |
45±5 |
166±4 |
67±7 |
Untreated |
|
24±3 |
17±5 |
45±5 |
179±16 |
58±8 |
Iron oxide isostearate |
33 100 333 1000 2500 5000 |
18±4 p 22±6 p 23±5 p 17±4 p 19±4 p 24±7 p |
14±1 p 11±3 p 16±6 p 13±3 p 16±2 p 12±4 p |
54±10 p 46±6 p 54±7 p 46±5 p 46±4 p 52±5 p |
166±39 p 149±16 p 161±26 p 145±29 p 169±15 p 175±6 p |
57±8 p 64±5 p 74±9 p 53±3 p 67±3 p 73±16 p |
2-AA |
2.5 |
357±4 |
401±19 |
2254±163 |
2507±139 |
|
2-AA |
10 |
|
|
|
|
501±26 |
NaN3: sodium azide
2-AA : 2-aminoanthracene
4-NOPD : 4-nitro-o-phenylene-diamine
MMS : methyl methane sulfonate
P : Precipitate
Applicant's summary and conclusion
- Conclusions:
- Under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used.
- Executive summary:
The mutagenic potential of Iron oxide isostearate was tested in a bacterial reverse mutation test according to OECD guideline 471 and GLP (RCC report No.A13961). The test substance was applied on four strains of Salmonella typhimurium (TA1535, TA1537, TA98 and TA100) and one strain of Escherichia coli (WP2 uvrA), using both plate incorporation and preincubation methods, at concentrations between 0 and 5000 µg/plate in ethanol, with or without metabolic activation. The appropriate positive controls were included and responded adequately.
On the day of the experiment, the test Iron oxide isostearate was suspended in ethanol. Precipitation in the overlay agar was observed from 33 µg/plate up to 5000 µg/plate with and without metabolic activation.
The plates incubated with the test item showed normal background growth up to 5000 µg/plate with and without metabolic activation in both independent experiments.
No toxic effects, evident as a reduction in the number of revertants, occurred in the test groups with and without metabolic activation. A reduction in the number of revertants was observed in experiment I without metabolic activation in strain TA 1537 at 3 µg/plate and 333 µg/plate. Since there is no dose dependent reduction and the values are still in the range of the historical control data, this effect is not judged as a real toxic effect.
No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with iron oxide isostearate at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance.
Appropriate reference mutagens were used as positive controls. They showed a distinct increase of induced revertant colonies.
Therefore, Iron oxide isostearate is considered to be non-mutagenic in this Salmonella typhimurium and Escherichia coli reverse mutation assay.
This study is classified as acceptable. It is compliant with the OECD 471 guideline requirements on bacterial reverse mutation test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.